
pmid: 7951004
The generation of drug resistant bone marrow may facilitate the development of aggressive chemotherapeutic regimens that might otherwise be lethal due to marrow toxicity. With the availability of technology that permits in vitro manipulation of human marrow and peripheral blood stem cells, it is now possible to introduce genes that confer drug resistance to these hematopoietic progenitors. Animal models and in vitro work with human progenitors using drug resistance genes are reviewed.
Genetic Vectors, Drug Resistance, Hematopoietic Stem Cell Transplantation, Antineoplastic Agents, Bone Marrow Cells, CHO Cells, Genetic Therapy, Haplorhini, Hematopoietic Stem Cells, Mice, Tetrahydrofolate Dehydrogenase, Dogs, Cricetinae, Animals, Humans, ATP Binding Cassette Transporter, Subfamily B, Member 1
Genetic Vectors, Drug Resistance, Hematopoietic Stem Cell Transplantation, Antineoplastic Agents, Bone Marrow Cells, CHO Cells, Genetic Therapy, Haplorhini, Hematopoietic Stem Cells, Mice, Tetrahydrofolate Dehydrogenase, Dogs, Cricetinae, Animals, Humans, ATP Binding Cassette Transporter, Subfamily B, Member 1
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 35 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
